These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 3128804)
1. Antagonism by ketanserin of the behavioral effects of quipazine but not l-5-hydroxytryptophan in squirrel monkeys. Witkin JM; Brady LS; Barrett JE Psychopharmacology (Berl); 1988; 94(3):302-5. PubMed ID: 3128804 [TBL] [Abstract][Full Text] [Related]
2. Antagonism by methysergide of the effects of L-5-hydroxytryptophan and quipazine on schedule-controlled responding. Leander JD Neuropharmacology; 1981 Dec; 20(12A):1141-3. PubMed ID: 6976522 [No Abstract] [Full Text] [Related]
3. Effects of serotonin receptor agonists and antagonists on schedule-controlled behavior of squirrel monkeys. Brady LS; Barrett JE J Pharmacol Exp Ther; 1985 Nov; 235(2):436-41. PubMed ID: 2932546 [TBL] [Abstract][Full Text] [Related]
4. Effects of serotonin agonists on operant behavior in the squirrel monkey: quipazine, MK-212, trifluoromethylphenylpiperazine, and chlorophenylpiperazine. McKearney JW Pharmacol Biochem Behav; 1990 Jan; 35(1):181-5. PubMed ID: 2315357 [TBL] [Abstract][Full Text] [Related]
5. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat. Jacoby JH; Bryce GF Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241 [TBL] [Abstract][Full Text] [Related]
6. Antagonism of the behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) and quipazine by metergoline. Commissaris RL; Rech RH Pharmacol Biochem Behav; 1981 Oct; 15(4):659-62. PubMed ID: 7291270 [TBL] [Abstract][Full Text] [Related]
7. Serotonin-antagonist effects of 1-(1-naphthyl)piperazine on operant behavior of squirrel monkeys. McKearney JW Neuropharmacology; 1989 Aug; 28(8):817-21. PubMed ID: 2779752 [TBL] [Abstract][Full Text] [Related]
10. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan. Yamamoto T; Walker EA; Woods JH J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of imipramine-induced rat brain beta-adrenoreceptor desensitization by subacute co-administration of trazodone, zimelidine, quipazine or 5-hydroxytryptophan. Alhaider AA; Mustafa AA Psychopharmacology (Berl); 1991; 103(3):351-6. PubMed ID: 1647538 [TBL] [Abstract][Full Text] [Related]
12. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists. Mokler DJ; Commissaris RL; Warner MR; Rech RH J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557 [TBL] [Abstract][Full Text] [Related]
13. Methysergide blocks the sleep suppressant action of quipazine in rats. Fornal C; Radulovacki M Psychopharmacology (Berl); 1982; 76(3):255-9. PubMed ID: 6808546 [TBL] [Abstract][Full Text] [Related]
14. 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats. Yocca FD; Wright RN; Margraf RR; Eison AS Pharmacol Biochem Behav; 1990 Jan; 35(1):251-4. PubMed ID: 2138331 [TBL] [Abstract][Full Text] [Related]
15. Serotonergic modulation of the discriminative-stimulus effects of cocaine in squirrel monkeys. Schama KF; Howell LL; Byrd LD Psychopharmacology (Berl); 1997 Jul; 132(1):27-34. PubMed ID: 9272756 [TBL] [Abstract][Full Text] [Related]
16. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon. Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625 [TBL] [Abstract][Full Text] [Related]
17. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour. Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559 [TBL] [Abstract][Full Text] [Related]
18. Adaptation of brain 5HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior. Smith RL; Barrett RJ; Sanders-Bush E J Pharmacol Exp Ther; 1990 Aug; 254(2):484-8. PubMed ID: 2166792 [TBL] [Abstract][Full Text] [Related]
19. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors. Hewson G; Leighton GE; Hill RG; Hughes J Br J Pharmacol; 1988 Oct; 95(2):598-604. PubMed ID: 2906561 [TBL] [Abstract][Full Text] [Related]